In a research report issued today, Cantor analyst Irina Rivkind Koffler maintained a Buy rating on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with an $8.50 price target, after …
Cantor analyst Irina Rivkind came out with a research note on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the company released its fourth-quarter results, posting a net loss of $30.6M and …
